TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9148548

Group type: EXPERIMENTAL
Intervention: Yellow fever vaccination
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study: 8256728

Group type: EXPERIMENTAL
Intervention: Anterior wall AMI
Number of subjects: 3981

Group type: COMPARATOR
Intervention: Inferior wall AMI
Number of subjects: 3981
Study: 3846198

Group type: EXPERIMENTAL
Intervention: Single-dose treatment with amoxicillin (3.0 g single dose)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional treatment with amoxicillin (250 mg three times daily for ten days)
Number of subjects: 31
Study: 31888504

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of remifentanil (group R)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Epidural group (group E)
Number of subjects: 80
Study: 28213783

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (doxorubicin, 5-fluorouracil/mitomycin, or epirubicin)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (paclitaxel)
Number of subjects: 364
Study: 24943918

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction for breast cancer survivors (MBSR(BC))
Number of subjects: 79
Study: 23392199

Group type: EXPERIMENTAL
Intervention: Sleep restriction (two-thirds of normal sleep time for 8 days/8 nights)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual sleep (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleep restriction
Number of subjects: 0
Study: 22186687

Group type: EXPERIMENTAL
Intervention: Glass fiber
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Polyethylene fiber
Number of subjects: 45

Group type: COMPARATOR
Intervention: Z250 composite resin without fibers (Control)
Number of subjects: 45
Study: 19536690

Group type: EXPERIMENTAL
Intervention: Observer perspective memories
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Field perspective memories
Number of subjects: 123
Study: 16441931

Group type: EXPERIMENTAL
Intervention: Processed complementary food (PCF)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Unprocessed complementary food (UPCF)
Number of subjects: 158
Study: 15065100

Group type: EXPERIMENTAL
Intervention: Decision analysis consultation
Number of subjects: 117

Group type: COMPARATOR
Intervention: Routine consultation
Number of subjects: 117
Study: 11132761

Group type: EXPERIMENTAL
Intervention: IV vitamin C 500 mg administered three times a week for three months
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no vitamin C for the first three months)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: IV vitamin C 500 mg administered three times a week for the second three months
Number of subjects: 27
Study: 9060568

Group type: EXPERIMENTAL
Intervention: Sucralfate solution
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 97
Study: 8453970

Group type: EXPERIMENTAL
Intervention: Amoxycillin (3 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ofloxacin (400 mg)
Number of subjects: 6
Study: 3513209

Group type: EXPERIMENTAL
Intervention: PGE2 vaginal film (850 ug)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Forewater amniotomy and I.V. oxytocin
Number of subjects: 111
Study: 30562268

Group type: EXPERIMENTAL
Intervention: i.v. morphine (0.09-mg/kg total)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: i.v. naloxone (12-mg total)
Number of subjects: 46

Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 46
Study: 29717840

Group type: EXPERIMENTAL
Intervention: TRUSC-guided administration of traditional Chinese medicine, qd for 7 days before TURP
Number of subjects: 167

Group type: COMPARATOR
Intervention: TURP only (Control)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: TRUSC-guided administration of traditional Chinese medicine
Number of subjects: 167
Study: 25458745

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (Group HES)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isolyte S® (Group ISO)
Number of subjects: 30
Study: 23570300

Group type: EXPERIMENTAL
Intervention: Filtek Silorane Restorative System
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Adper Scotchbond 1 XT with Filtek Z250
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Adper Scotchbond SE with Filtek Z250
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: All systems
Number of subjects: 25
Study: 21355158

Group type: EXPERIMENTAL
Intervention: String puncture combined with electroacupuncture
Number of subjects: 95

Group type: COMPARATOR
Intervention: Routine manipulations (control group)
Number of subjects: 95
Study: 18359021

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 120
Study: 16825669

Group type: EXPERIMENTAL
Intervention: Intervention group (asthma coaching + monetary incentive)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (usual discharge instructions)
Number of subjects: 92
Study: 12825062

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg diazepam and 0.015 mg/kg atropine sulfate
Number of subjects: 50

Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 50
Study: 10942103

Group type: EXPERIMENTAL
Intervention: Hospital intervention utilizing medical opinion leaders and performance feedback
Number of subjects: 28

Group type: COMPARATOR
Intervention: Performance feedback only (Control)
Number of subjects: 28
Study: 8696444

Group type: EXPERIMENTAL
Intervention: Survival curves and relative risk estimates derived from a proportional hazards analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Demographic factors (sex, age)
Number of subjects: 0
Study: 1646881

Group type: EXPERIMENTAL
Intervention: Subcuticular polyglycolic acid
Number of subjects: 126

Group type: COMPARATOR
Intervention: Interrupted monofilament nylon mattress sutures
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Overall infection rate
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Procedures by surgeons with highest infection rates
Number of subjects: 126

Group type: COMPARATOR
Intervention: Procedures by remaining surgeons
Number of subjects: 126
Study: 6661346

Group type: EXPERIMENTAL
Intervention: 100 mg AQ‐A 39
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg AQ‐A 39
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 30085285

Group type: EXPERIMENTAL
Intervention: Brief pain screening measures
Number of subjects: 24
Study: 30131099

Group type: EXPERIMENTAL
Intervention: Home telemonitoring for blood pressure delivered by a team comprising a GP, a hypertension specialist, a general nurse and an information manager.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Home telemonitoring (intervention group).
Number of subjects: 110
Study: 26655084

Group type: EXPERIMENTAL
Intervention: NS11821 (10 mg, 30 mg, 75 mg, 150 mg, 300 mg, 600 mg)
Number of subjects: 48
Study: 25834495

Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation programme (PRP) for 6 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study: 22785325

Group type: EXPERIMENTAL
Intervention: Sulfamethazine (SMZ) 0.2%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study: 20814315

Group type: EXPERIMENTAL
Intervention: Low-dose risperidone plus low-dose haloperidol (2 mg/d risperidone + 2 mg/d haloperidol)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Risperidone monotherapy (4 mg/d risperidone)
Number of subjects: 88
Study: 17905486

Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine (VAQTA) administered at 6 and 12 months of age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hexavalent vaccine (HEXAVAC) administered at 2, 4, 6, and 12 months of age
Number of subjects: 0
Study: 15677625

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy plus ovarian suppression (either radiation-induced ovarian ablation or triptorelin for 3 years)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy alone (control arm)
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: Ovarian suppression in patients <40 years of age with estrogen receptor-positive tumors
Number of subjects: 926
Study: 12407637

Group type: EXPERIMENTAL
Intervention: Total homocysteine (tHcy) levels
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Cysteine levels
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: B vitamin levels (folate, PLP, vitamin B12)
Number of subjects: 804
Study: 10334434

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Angioplasty
Number of subjects: 0
Study: 8624122

Group type: EXPERIMENTAL
Intervention: Besipirdine 5 mg BID
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Besipirdine 20 mg BID
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Clinical global rating
Number of subjects: 275
Study: 1923396

Group type: EXPERIMENTAL
Intervention: Topical medication containing tannic acid
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 6978010

Group type: EXPERIMENTAL
Intervention: Conray 60
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sinografin
Number of subjects: 40
Study: 30721296

Group type: EXPERIMENTAL
Intervention: EEG-guided anesthetic administration
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Usual anesthetic care
Number of subjects: 1232
Study: 28346333

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fish oil with primrose evening oil supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 60
Study: 26715763

Group type: EXPERIMENTAL
Intervention: Intradialytic resistance training using resistance elastic bands in a seated position during the first hour of haemodialysis treatment for 12, 24 or 36 weeks
Number of subjects: 171
Study: 24788929

Group type: EXPERIMENTAL
Intervention: Warm climate rehabilitation programme
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Cold climate rehabilitation programme
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 132
Study: 22760081

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment
Number of subjects: 60
Study: 19527468

Group type: EXPERIMENTAL
Intervention: Polaprezinc (34 mg/day)
Number of subjects: 117
Study: 17264781

Group type: EXPERIMENTAL
Intervention: rh-TSH treated patients (17 patients)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Hypothyroid patients (14 patients)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: rh-TSH treated patients (10 patients)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Hypothyroid patients (21 patients)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: rh-TSH treated patients
Number of subjects: 46

Group type: COMPARATOR
Intervention: Hypothyroid patients
Number of subjects: 46
Study: 15554347

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler with pCO2 challenge
Number of subjects: 17

Group type: COMPARATOR
Intervention: Age-matched healthy nondiabetic controls
Number of subjects: 17
Study: 11475220

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (100% atmospheres, 3 litres/minute) for 24 hours
Number of subjects: 550

Group type: COMPARATOR
Intervention: Control (no additional oxygen)
Number of subjects: 550
Study: 9330939

Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation of AC joints
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 95

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 95

Group type: COMPARATOR
Intervention: CT
Number of subjects: 95

Group type: COMPARATOR
Intervention: Radiography
Number of subjects: 95
Study: 7903217

Group type: EXPERIMENTAL
Intervention: Tertatolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study: 3519285

Group type: EXPERIMENTAL
Intervention: 6 courses of a 'CMF like' chemotherapy
Number of subjects: 248

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 248
Study: 3146465

Group type: EXPERIMENTAL
Intervention: Sodium fusidate ointment
Number of subjects: 354

Group type: COMPARATOR
Intervention: Mupirocin ointment
Number of subjects: 354
Study: 31437703

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 57

Group type: COMPARATOR
Intervention: Escitalopram/Venlafaxine
Number of subjects: 57
Study: 25935145

Group type: EXPERIMENTAL
Intervention: 0.33% ropivacaine by pump through the wound
Number of subjects: 71

Group type: COMPARATOR
Intervention: Intravenous delivery of flurbiprofen axetil, pentazocine and palonosetron via intravenous pump
Number of subjects: 71
Study: 25437180

Group type: COMPARATOR
Intervention: Ensure Liquid (EL)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Inner Power (IP)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: EL + IP
Number of subjects: 27
Study: 23298553

Group type: EXPERIMENTAL
Intervention: Co-enrolled patients in thromboprophylaxis trial
Number of subjects: 3746

Group type: COMPARATOR
Intervention: Non-co-enrolled patients in thromboprophylaxis trial
Number of subjects: 3746
Study: 22000847

Group type: EXPERIMENTAL
Intervention: Oral fluconazole 150 mg single dose
Number of subjects: 142

Group type: COMPARATOR
Intervention: Intra-vaginal clotrimazole 200 mg per day for six days
Number of subjects: 142
Study: 18374245

Group type: EXPERIMENTAL
Intervention: Neo-traditional neighborhoods (experimental group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional suburban neighborhoods (control group)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Environmental factors (e.g., fewer culs-de-sac)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Land-use mix
Number of subjects: 32
Study: 16927177

Group type: EXPERIMENTAL
Intervention: Divalproex sodium (DVPX)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 71
Study: 12839615

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate foam (BVF)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Betamethasone dipropionate lotion (BDL)
Number of subjects: 61
Study: 10607678

Group type: EXPERIMENTAL
Intervention: High-dose therapy with autologous stem cell support (NMSG #5/94)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control group (historic population)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: All registered patients in both populations
Number of subjects: 348
Study: 9252721

Group type: EXPERIMENTAL
Intervention: FEMP+PSK (5-fluorouracil, cyclophosphamide, mitomycin C, predonisolone + 3.0 g of PSK)
Number of subjects: 134

Group type: COMPARATOR
Intervention: FEMP (5-fluorouracil, cyclophosphamide, mitomycin C, predonisolone)
Number of subjects: 134

Group type: COMPARATOR
Intervention: NA (no adjuvant therapy)
Number of subjects: 134
Study: 1556679

Group type: EXPERIMENTAL
Intervention: Sodium Meclofenamate (Meclomen) 100 mg po tid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac Sodium (Voltaren) 25 mg po tid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both Meclomen and Voltaren
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WOMAC Osteoarthritis Index
Number of subjects: 0
Study: 3905199

Group type: EXPERIMENTAL
Intervention: Venous digital subtraction angiography
Number of subjects: 28

Group type: COMPARATOR
Intervention: Aortography
Number of subjects: 28
Study: 30342554

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) therapy, 16 mg per day (8 mg twice daily, days 1 to 4), halved every 3 days until 0.5 mg on day 19, stopped on day 20.
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) therapy
Number of subjects: 420

Group type: COMPARATOR
Intervention: Burr-hole craniotomy (BHC)
Number of subjects: 420
Study: 27232899

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide solution (H2O2) for 3 months
Number of subjects: 131

Group type: COMPARATOR
Intervention: Biguanide‐preserved multipurpose solution (BMPS) for 3 months
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide solution (H2O2)
Number of subjects: 131
Study: 24405579

Group type: EXPERIMENTAL
Intervention: Treatment group received access to a 'Rolling Store', nutrition education, and physical activity.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group received family coping classes.
Number of subjects: 49
Study: 23239249

Group type: EXPERIMENTAL
Intervention: Provider job aid intervention for managing late-returning clients
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Control group (no job aid)
Number of subjects: 5000
Study: 20179024

Group type: EXPERIMENTAL
Intervention: Interactive, immersive virtual pedestrian environment
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Pedestrian safety training via widely used video and computer strategies
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Individualised behavioural training at streetside locations
Number of subjects: 240

Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 240
Study: 18757179

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 9
Study: 16463811

Group type: EXPERIMENTAL
Intervention: Cumulative percent time below CPP thresholds (55 mm Hg)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Cumulative percent time below CPP thresholds (60 mm Hg)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Cumulative percent time below CPP thresholds (65 mm Hg)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Cumulative percent time below CPP thresholds (70 mm Hg)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Cumulative percent time below CPP thresholds
Number of subjects: 157
Study: 12358368

Group type: EXPERIMENTAL
Intervention: Gentamicin (5 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cefuroxime (1.5 g)
Number of subjects: 20
Study: 10748445

Group type: EXPERIMENTAL
Intervention: Tumor consistency measurement in pathologically positive node group (PN[+]) in T1
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Tumor consistency measurement in pathologically negative node group (PN[-]) in T1
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Tumor consistency measurement in pathologically positive node group (PN[+]) in T2
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Tumor consistency measurement in pathologically negative node group (PN[-]) in T2
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: N0 patients with pathologically positive node group (PN[+])
Number of subjects: 53
Study: 8809610

Group type: EXPERIMENTAL
Intervention: Recombinant human interferon‐alpha 2b, 0.5 million per cm2 of keloid, injected into one lesional site
Number of subjects: 22

Group type: COMPARATOR
Intervention: Diluent alone injected into another lesional site
Number of subjects: 22
Study: 1301128

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic medications
Number of subjects: 1498

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1498
Study: 3516257

Group type: EXPERIMENTAL
Intervention: Cetiedil at 0.4 mg/kg body weight
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 30952602

Group type: EXPERIMENTAL
Intervention: ECGs with a checklist of syncope-related etiologies
Number of subjects: 165

Group type: COMPARATOR
Intervention: ECGs without a checklist
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: ECGs with a checklist
Number of subjects: 165
Study: 29432967

Group type: EXPERIMENTAL
Intervention: Timothy grass SLIT‐T taken once daily for 4 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo taken once daily for 4 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timothy grass SLIT‐T
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29052340

Group type: EXPERIMENTAL
Intervention: Lopinavir (LPV) based ART
Number of subjects: 105

Group type: COMPARATOR
Intervention: Non-nucleoside reverse transcriptase inhibitor (NNRTI) based ART
Number of subjects: 105
Study: 25732273

Group type: EXPERIMENTAL
Intervention: Low-amount, low-intensity exercise (LALI)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: High-amount, low-intensity exercise (HALI)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: High-amount, high-intensity exercise (HAHI)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: All exercise groups
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 300
Study: 24050970

Group type: EXPERIMENTAL
Intervention: Eperisone hydrochloride (3 doses of 50 mg each)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aceclofenac (2 doses of 100 mg each)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of eperisone hydrochloride and aceclofenac
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 20091161

Group type: EXPERIMENTAL
Intervention: Ticagrelor 100-400 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 18241749

Group type: EXPERIMENTAL
Intervention: Endovascular repair (EVAR)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 345
Study: 16874563

Group type: EXPERIMENTAL
Intervention: Matching-to-sample procedure with varying retention intervals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Matching-to-sample procedure
Number of subjects: 0
Study: 12802748

Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone (1 g daily for 7 days; n=87)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Intravenous sodium penicillin G (1.5 million U every 6 h for 7 days; n=86)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 173

Group type: COMPARATOR
Intervention: Sodium penicillin G
Number of subjects: 173
Study: 10566924

Group type: EXPERIMENTAL
Intervention: 75 microg oral clonidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 150 microg oral clonidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8619356

Group type: EXPERIMENTAL
Intervention: iobitridol 300
Number of subjects: 180

Group type: COMPARATOR
Intervention: iohexol 300
Number of subjects: 180